University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Behavioral Research of Environment and Air Pollution Through Education

Not Applicable

Conditions: Attitude to Health
Pollution Related Respiratory Disorder
Health Behavior

Interventions: Behavioral: Air Pollution Education
Other: Non-Air Pollution Education

First Posted Date: 2015-06-15

Last Posted Date: 2018-12-13

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 600

Registration Number: NCT02471872

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Clinical Pharmacology of Electronic Cigarettes

Not Applicable

Completed

Conditions: Nicotine Dependence

Interventions: Device: Tobacco Cigarette
Device: Electronic Cigarette

First Posted Date: 2015-06-12

Last Posted Date: 2023-06-22

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 38

Registration Number: NCT02470754

Locations: 🇺🇸
San Francisco General Hospital (SFGH), San Francisco, California, United States
🇺🇸
University of California, San Francisco (UCSF), San Francisco, California, United States

Pilot of Letrozole for Uterine Myomas

Phase 4

Completed

Conditions: Leiomyoma
Uterine Fibroids

Interventions: Drug: Letrozole
Other: Placebo

First Posted Date: 2015-06-12

Last Posted Date: 2019-11-15

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 12

Registration Number: NCT02470741

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Web-based Lifestyle Trial Among Men With Prostate Cancer: Prostate 8

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Behavioral: Lifestyle intervention

First Posted Date: 2015-06-12

Last Posted Date: 2019-02-22

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 76

Registration Number: NCT02470936

Locations: 🇺🇸
University of California, San Francisco (UCSF), San Francisco, California, United States

The Effects of Oxytocin on Startle Hyperreactivity in Patients With AUD and PTSD

Early Phase 1

Completed

Conditions: Stress Disorders, Post-Traumatic
Alcoholism

Interventions: Drug: Oxytocin
Other: Placebo

First Posted Date: 2015-06-11

Last Posted Date: 2019-05-21

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 88

Registration Number: NCT02469259

Locations: 🇺🇸
San Francisco Veterans Affairs Medical Center, San Francisco, California, United States

A Randomized Controlled Trial of IV Ketorolac to Prevent Post-ERCP Pancreatitis

Phase 4

Withdrawn

Conditions: Pancreatitis

Interventions: Drug: Placebo
Drug: Ketorolac

First Posted Date: 2015-06-08

Last Posted Date: 2022-04-28

Lead Sponsor: University of California, San Francisco

Registration Number: NCT02465138

Locations: 🇺🇸
UCSF/San Francisco General Hospital, San Francisco, California, United States
🇺🇸
San Francisco General Hospital, San Francisco, California, United States

San Francisco Health Plan Care Support Trial

Not Applicable

Completed

Conditions: Case Management
Managed Care Program

Interventions: Other: Care Support Intervention

First Posted Date: 2015-06-04

Last Posted Date: 2019-01-15

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 292

Registration Number: NCT02463838

Locations: 🇺🇸
San Francisco Health Plan, San Francisco, California, United States

Fecal Microbiota Transplant for Inflammatory Bowel Disease

Early Phase 1

Completed

Conditions: Inflammatory Bowel Disease

Interventions: Drug: Biologically active human fecal material, OpenBiome

First Posted Date: 2015-06-02

Last Posted Date: 2018-06-21

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 59

Registration Number: NCT02460705

Locations: 🇺🇸
UCSF Division of Gastroenterology at Mount Zion, San Francisco, California, United States

Young Plasma Transfusions for Progressive Supranuclear Palsy

Phase 1

Completed

Conditions: Progressive Supranuclear Palsy

Interventions: Biological: Fresh Frozen Plasma

First Posted Date: 2015-06-02

Last Posted Date: 2020-08-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 6

Registration Number: NCT02460731

Locations: 🇺🇸
University of California, San Francisco, Memory and Aging Center, San Francisco, California, United States

Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation

Phase 2

Completed

Conditions: Juvenile Myelomonocytic Leukemia
Myelodysplastic Syndrome
Acute Myelogenous Leukemia
Acute Lymphoid Leukemia

Interventions: Drug: azacitidine
Biological: donor lymphocyte infusion

First Posted Date: 2015-06-01

Last Posted Date: 2020-10-12

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 17

Registration Number: NCT02458235

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy